Lipoid congenital adrenal hyperplasia epidemiology and demographics

Lipoid congenital adrenal hyperplasia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lipoid CAH from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lipoid congenital adrenal hyperplasia epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lipoid congenital adrenal hyperplasia epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lipoid congenital adrenal hyperplasia epidemiology and demographics
CDC on Lipoid congenital adrenal hyperplasia epidemiology and demographics
Lipoid congenital adrenal hyperplasia epidemiology and demographics in the news
Blogs on Lipoid congenital adrenal hyperplasia epidemiology and demographics
Directions to Hospitals Treating Lipoid congenital adrenal hyperplasia
Risk calculators and risk factors for Lipoid congenital adrenal hyperplasia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

Lipoid CAH is quite rare in European and North American populations. Most cases have occurred in Japan and Korea (where the incidence is 1 in 300,000 births) and Palestinian Arabs. Despite autosomal recessive inheritance, there has been an unexplained preponderance of genetic females in reported cases